Drug Profile
Research programme: apoptosis inducers - Advanced Life Sciences
Alternative Names: ALS-769; ALS-851Latest Information Update: 06 May 2011
Price :
$50
*
At a glance
- Originator Advanced Life Sciences
- Class Triterpenes
- Mechanism of Action Apoptosis stimulants; Caspase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Suspended Cancer
Most Recent Events
- 06 May 2011 Suspended - Preclinical for Cancer in USA (unspecified route)
- 02 Apr 2009 Preclinical development is ongoing in the US
- 28 Sep 2006 Preclinical trials in Cancer in USA (unspecified route)